Projects funded by the NCN
Assessment of SARS-CoV-2 infection in patients with chronic lymphocytic leukemia depending on indicators of immune disorders, with particular emphasis on the role of interferons as natural compounds with therapeutic potential
2021/41/B/NZ6/01765
Keywords:
interferons chronic lymphocytic leukemia anti-coronavirus disease 2019 (COVID-19) vaccine Epstein-Barr virus (EBV) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) secondary immunodeficiency zebrafish interferonopathies
Descriptors:
- NZ6_1: Adaptive and innate immunity
- NZ6_2: Clinical immunology
Panel:
NZ6 - Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution :
Uniwersytet Medyczny w Lublinie
woj. lubelskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 7
Call: OPUS 21 - announced on 2021-03-15
Amount awarded: 1 999 647 PLN
Project start date (Y-m-d): 2022-02-01
Project end date (Y-m-d): 2026-01-31
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.